Gordian Surgical’s TroClose1200™ is a novel integrated port closure system.
The TroClose1200 offers surgeons a simple, secure, and safe solution to open and close the abdominal wall during laparoscopic procedures.
Instead of inserting closure sutures in the fascia at the end of a procedure, Gordian’s uniquely designed “two-in-one” trocar efficiently inserts sutures into the tissue surrounding the cannula at the beginning of the procedure. When the cannula is removed, the surgeon closes the fascia by simply tying the TroClose 1200 sutures together.
Gordian’s TroClose1200 can be adapted to all types of trocars: bladed/bladeless, disposable/multiuse, and others.
Founded: November 2012
Stage: Business development
Investors: The Trendlines Group, B. Braun, private investment funds (China and Canada), private investors, including key opinion leaders (surgeons)
An estimated 10 million laparoscopic procedures are performed annually. While laparoscopic surgeries are less invasive, closing abdominal access ports remains a difficult and time-consuming task. Today, surgeons manually suture ports with a needle and thread, adding up to 20 minutes per operation. Some surgeons use a dedicated closure device, rather than needle and thread, adding significantly to procedure cost and presenting safety problems.
The global trocar and closure markets have yearly revenues of approximately $1 billion and $450 million, respectively. According to MarketStrat, J&J dominates the trocar market (50%), followed by Covidien (30%) and Applied Medical (15%).
Marketing Director Doni Mayerfeld interviewed on ILTV.
CEO Zvi Peer presents at Trendlines 7th Annual Company Showcase in 2017.
See the company 1-page description in Chinese (PDF).
Endoscopic ultrasound fine needle biopsy
Portable, automatic system for peritoneal dialysis
Device for treating ischemic stroke
Anastomotic closure device for laparoscopic bowel resection
Miniature screwless spine fusion implant